Onkure Therapeutics, Inc. · NASDAQ:OKUR
Lundbeckfond Invest A/S's stake in Onkure Therapeutics, Inc. fell to 1.60% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 6, 2025
Lundbeckfond Invest A/S's stake in Onkure Therapeutics, Inc. fell to 1.60%, 203,122 shares, as a passive investor on Dec 31, 2024. Filed Feb 6, 2025 (Schedule 13G/A).
- Stake
- 1.60%
- Shares
- 203,122
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Lundbeckfond Invest A/S | 1.60% | 203,122 |
| Lene Skole | 1.60% | 203,122 |
Source
Related
- Onkure Therapeutics, Inc.
- Lundbeckfond Invest A/S
- Onkure Therapeutics, Inc. shareholders
- Schedule 13G · Coastlands Capital LP · Oct 7, 2026
- Form 4 · Saccomano Nicholas A · Sep 23, 2026
- Form 4 · Leverone Jason A. · Sep 23, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026